These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 489768)

  • 1. Sotalol: another beta adrenergic blocking agent?
    Ahlquist RP
    J Clin Pharmacol; 1979; 19(8-9 Pt 2):495-6. PubMed ID: 489768
    [No Abstract]   [Full Text] [Related]  

  • 2. Plasma clearance of propranolol and sotalol and hepatic drug-metabolizing enzyme activity.
    Sotaniemi EA; Anttila M; Pelkonen RO; Järvensivu P; Sundquist H
    Clin Pharmacol Ther; 1979 Aug; 26(2):153-61. PubMed ID: 455885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single-dose kinetics of oral propranolol, metoprolol, atenolol, and sotalol: relation to lipophilicity.
    Ochs HR; Greenblatt DJ; Arendt RM; Schäfer-Korting M; Mutschler E
    Arzneimittelforschung; 1985; 35(10):1580-2. PubMed ID: 2866772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Propranolol and sotalol metabolism after a drinking party.
    Sotaniemi EA; Anttila M; Rautio A; Stengård J; Saukko P; Järvensivu P
    Clin Pharmacol Ther; 1981 Jun; 29(6):705-10. PubMed ID: 7226702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of propranolol and sotalol in hyperthyroidism.
    Aro A; Anttila M; Korhonen T; Sundquist H
    Eur J Clin Pharmacol; 1982; 21(5):373-7. PubMed ID: 7075642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of arterial hypertension with sotalol, a beta-blocker (author's transl)].
    Klein G; Schnelle K; Schinz A; Oberländer V
    Dtsch Med Wochenschr; 1977 Apr; 102(15):563-9. PubMed ID: 849711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronopharmacokinetics of beta-receptor blocking drugs of different lipophilicity (propranolol, metoprolol, sotalol, atenolol) in plasma and tissues after single and multiple dosing in the rat.
    Lemmer B; Winkler H; Ohm T; Fink M
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Jul; 330(1):42-9. PubMed ID: 2864639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of sotalol and propranolol in mild to moderate essential hypertension.
    Pessina AC; Hlede M; Morandin F; Casiglia E; Gava R; Agnoletto V; Locatelli C; Dal Palu C
    Int J Clin Pharmacol Res; 1983; 3(1):41-5. PubMed ID: 6679506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical pharmacology of adrenergic beta receptor blockade with sotalol (MJ 1999)].
    Schnelle K
    Adv Clin Pharmacol; 1978; 18():1-111. PubMed ID: 212935
    [No Abstract]   [Full Text] [Related]  

  • 10. Antihypertensive effect of sotalol and propranolol a double-blind crossover study.
    Berglund G
    Curr Ther Res Clin Exp; 1977 Jan; 21(1):21-7. PubMed ID: 401708
    [No Abstract]   [Full Text] [Related]  

  • 11. [Comparative pharmacokinetics of beta-blockers].
    Kiechel JR; Meier J
    Nouv Presse Med; 1978 Sep; 7(31):2685-7. PubMed ID: 30943
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparative antihypertensive effects and tissue distribution of beta adrenergic blocking drugs.
    Garvey HL; Ram N
    J Pharmacol Exp Ther; 1975 Jul; 194(1):220-33. PubMed ID: 1151751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on the pharmacokinetics and pharmacodynamics of the beta-adrenergic blocking agent sotalol in normal man.
    Schnelle K; Klein G; Schinz A
    J Clin Pharmacol; 1979; 19(8-9 Pt 2):516-22. PubMed ID: 489770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Therapeutic indications for sotalol 160 mg].
    Ginestes J
    Ann Cardiol Angeiol (Paris); 1985 Jan; 34(1):45-52. PubMed ID: 2579609
    [No Abstract]   [Full Text] [Related]  

  • 15. Sotalol, a pure beta-adrenergic blocking agent for treatment of essential hypertension and other cardiovascular diseases.
    Aviado DM
    J Clin Pharmacol; 1979; 19(8-9 Pt 2):497-504. PubMed ID: 385636
    [No Abstract]   [Full Text] [Related]  

  • 16. Transfer of propranolol and sotalol across the human placenta. Their effect on maternal and fetal plasma renin activity.
    Erkkola R; Lammintausta R; Liukko P; Anttila M
    Acta Obstet Gynecol Scand; 1982; 61(1):31-4. PubMed ID: 7046334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High plasma protein binding as a parameter in the selection of betablockers for lactating women.
    Riant P; Urien S; Albengres E; Duche JC; Tillement JP
    Biochem Pharmacol; 1986 Dec; 35(24):4579-81. PubMed ID: 2878668
    [No Abstract]   [Full Text] [Related]  

  • 18. [Treatment of hypertension with Sotalol (author's transl)].
    Fillastre JP; Godin M; Joire JE; Gauthier A
    Sem Hop; 1979 Nov 18-25; 55(39-40):1825-31. PubMed ID: 232780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sotalol as a hypotensive agent in pregnancy.
    O'Hare MF; Murnaghan GA; Russell CJ; Leahey WJ; Varma MP; McDevitt DG
    Br J Obstet Gynaecol; 1980 Sep; 87(9):814-20. PubMed ID: 7426541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transfer of beta blocking drugs from the amniotic fluid to the fetal and maternal circulation.
    Van Petten GR; Mears GJ; Mathison HJ
    J Pharmacol Exp Ther; 1978 Nov; 207(2):641-9. PubMed ID: 712646
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.